---
phase: 10-pairing-sql-reconciliation
plan: "01"
subsystem: pairing-engine
tags: [contamination-audit, sculptra-tiers, review-cards, quality-gate]
dependency_graph:
  requires: [09-podcast-data-strategy-and-evidence-provenance/EVIDENCE_MODEL.md, PAIRING_RUBRIC.md]
  provides: [CONTAMINATION_AUDIT.md, SCULPTRA_TIER_EVALUATION.md, clean-review-cards]
  affects: [10-02-PLAN.md (SQL regeneration gates on this audit being complete)]
tech_stack:
  added: []
  patterns: [EVIDENCE_MODEL.md contamination patterns, PAIRING_RUBRIC.md tier criteria]
key_files:
  created:
    - .planning/phases/10-pairing-sql-reconciliation/CONTAMINATION_AUDIT.md
    - .planning/phases/10-pairing-sql-reconciliation/SCULPTRA_TIER_EVALUATION.md
  modified:
    - REVIEW_QUEUE/pairings/botox_cosmetic__sculptra_aesthetic.md (tier: conditional → common)
    - REVIEW_QUEUE/pairings/daxxify__sculptra_aesthetic.md (tier: conditional → common)
    - REVIEW_QUEUE/pairings/dysport__sculptra_aesthetic.md (tier: conditional → common)
    - REVIEW_QUEUE/pairings/jeuveau__sculptra_aesthetic.md (tier: conditional → common)
    - REVIEW_QUEUE/pairings/xeomin__sculptra_aesthetic.md (tier: conditional → common + antibody language fixed)
    - REVIEW_QUEUE/pairings/botox_cosmetic__inmode_morpheus8.md (Gate 6 certainty softened)
    - REVIEW_QUEUE/pairings/botox_cosmetic__juvederm_voluma_xc.md ("superior results" → "published evidence supports")
    - REVIEW_QUEUE/pairings/botox_cosmetic__skinvive_by_juvederm.md (Gate 6 certainty softened)
decisions:
  - "[Phase 10-01]: 5 neurotoxin + Sculptra pairs promoted to common tier — orthogonal mechanisms (neuromodulation vs collagen stimulation) and 7/8 gate pass satisfies common rubric threshold"
  - "[Phase 10-01]: 6 Sculptra pairs remain conditional — HA/SKINVIVE pairs have overlapping tissue territory; Sculptra + Morpheus8 has expert-consensus-only evidence"
  - "[Phase 10-01]: Same-session framing updated to conditional for all 5 promoted neurotoxin+Sculptra pairs — FDA label caveat must be discussed with patients even though tier is common"
  - "[Phase 10-01]: Xeomin antibody language must not claim Xeomin prevents antibody formation — say it is a consideration some providers weigh, not a guarantee"
  - "[Phase 10-01]: All 37 review cards were already clean of podcast contamination — primary contamination source is the SQL files (scope of Plan 02), not the review cards"
metrics:
  duration: "~45 minutes"
  completed: "2026-06-14"
  tasks: 2
  files: 9
requirements: [POD-04, PAIR-02, PAIR-03]
---

# Phase 10 Plan 01: Contamination Audit + Sculptra Tier Re-Evaluation Summary

Contamination audit of all 37 review cards (zero podcast attribution found), light revisions per Chris feedback (Xeomin antibody softening, certainty reduction, SKINVIVE FDA framing), and Sculptra tier re-evaluation promoting 5 neurotoxin pairs from conditional to common based on documented mechanism-based reasoning.

## Tasks Completed

| Task | Name | Commit | Status |
|------|------|--------|--------|
| 1 | Contamination audit of 37 review cards + light revisions | 4388668 | DONE |
| 2 | Sculptra tier re-evaluation against Chris feedback | 897dae7 | DONE |

## Artifacts Produced

### CONTAMINATION_AUDIT.md
- 37 cards audited — all confirmed CLEAN of podcast contamination
- Contamination patterns checked: speaker names (Dr. Teri Fisher, Tracy Mancuso), show names, episode UUIDs, "podcast expert/consensus/show", PHASE_6_ANSWERS file paths
- 4 cards received light revisions (Task 1 commit 4388668)
- Conclusion: prior session had already removed podcast attribution from cards; primary contamination is in the SQL files (Plan 02 scope)

### SCULPTRA_TIER_EVALUATION.md
- All 11 Sculptra pairs evaluated with documented decision framework
- 5 neurotoxin + Sculptra pairs promoted from conditional to common
- 6 pairs confirmed as conditional with explicit justification
- FDA combination caveat confirmed present in all 11 cards

## Changes Applied

### Task 1: Contamination Audit + Light Revisions

**Contamination result:** Zero matches found across all 37 cards for any of the 8 contamination patterns.

**Light revisions applied:**
1. **Certainty reduction (3 cards):**
   - `botox_cosmetic__inmode_morpheus8.md` Gate 6: "comprehensive rejuvenation" → "addresses multiple aging mechanisms"
   - `botox_cosmetic__skinvive_by_juvederm.md` Gate 6: "comprehensive rejuvenation" → "addressing multiple patient concerns through distinct mechanisms"
   - `botox_cosmetic__juvederm_voluma_xc.md` clinical_rationale: "superior results to either modality alone" → "published evidence supports combination use...with data suggesting enhanced outcomes"

2. **Xeomin antibody language (1 card — xeomin__sculptra_aesthetic.md):**
   - Gate 6: "Xeomin's lower antibody risk" → "Xeomin's accessory-protein-free formulation is a consideration some providers weigh"
   - Timing Guidance: "lower antibody formation risk" → "accessory-protein-free formulation is a consideration some providers weigh"
   - Staff Talking Points: "the lower antibody risk is a genuine clinical consideration" → explicitly states it "does not prevent antibody formation, but some providers find it relevant for extended treatment plans"
   - Evidence: "lower antibody formation risk" → "does not contain the accessory proteins found in some other neurotoxins, which some providers consider relevant for long-term treatment plans"
   - Note: Other 5 Xeomin cards already used properly hedged "consideration" language — no changes needed

3. **SKINVIVE framing:** All 7 SKINVIVE cards already correctly framed SKINVIVE as skin quality/hydration only (not volume correction or contouring). No changes needed.

### Task 2: Sculptra Tier Re-Evaluation

**Decision framework:**
- Common threshold per rubric: 7-8 gates pass + 1+ source
- Neurotoxin + Sculptra: 7 gates PASS, Gate 8 PARTIAL (expert consensus = qualifies as 1 source)
- Mechanism complementarity is orthogonal (neuromodulation vs collagen stimulation = completely different biological processes)
- HA/SKINVIVE + Sculptra: both injectable, overlapping tissue territory, requires sequencing conditions → conditional is correct

**Tier changes:**

| Pair | Old | New | Reason |
|------|-----|-----|--------|
| Botox + Sculptra | conditional | common | Orthogonal mechanisms; 7/8 gates; expert consensus |
| Daxxify + Sculptra | conditional | common | Orthogonal mechanisms; extended duration alignment |
| Dysport + Sculptra | conditional | common | Orthogonal mechanisms; Galderma ecosystem |
| Jeuveau + Sculptra | conditional | common | Orthogonal mechanisms; moderate strength (limited Jeuveau-specific data) |
| Xeomin + Sculptra | conditional | common | Orthogonal mechanisms; accessory-protein-free consideration |
| Juvederm Vollure XC + Sculptra | conditional | conditional | Both injectable, overlapping territory |
| Juvederm Voluma XC + Sculptra | conditional | conditional | Both injectable, overlapping territory |
| Restylane Lyft + Sculptra | conditional | conditional | Both injectable, overlapping territory |
| RHA Redensity + Sculptra | conditional | conditional | Both injectable, sequencing required |
| SKINVIVE + Sculptra | conditional | conditional | Chris rows 26-31 feedback; same-session must be conditional |
| Sculptra + InMode Morpheus8 | conditional | conditional | Expert consensus only; sequencing varies |

**All 5 promoted cards:** same_session_ok updated to conditional framing with explicit FDA caveat. Phase 10 re-evaluation note added to header.

## Deviations from Plan

None — plan executed exactly as written. All acceptance criteria met.

## Verification Results

1. `grep -rl "podcast expert|podcast consensus|PHASE_6_ANSWERS|Dr. Teri|Tracy Mancuso" REVIEW_QUEUE/pairings/` → empty (EXIT:1 = no matches)
2. `grep -c "complete rejuvenation" REVIEW_QUEUE/pairings/*.md` → 0 for all files
3. CONTAMINATION_AUDIT.md exists with 37 rows in per-card table — CONFIRMED
4. SCULPTRA_TIER_EVALUATION.md exists with 11 rows — CONFIRMED
5. All Sculptra cards reference FDA combination caveat — CONFIRMED (verified by grep count)

## Known Stubs

None — all content fields in modified cards are fully populated. No placeholder text remains.

## Self-Check: PASSED

- CONTAMINATION_AUDIT.md: exists at .planning/phases/10-pairing-sql-reconciliation/CONTAMINATION_AUDIT.md
- SCULPTRA_TIER_EVALUATION.md: exists at .planning/phases/10-pairing-sql-reconciliation/SCULPTRA_TIER_EVALUATION.md
- Task 1 commit 4388668: exists
- Task 2 commit 897dae7: exists
- All 5 neurotoxin + Sculptra tiers: common (verified by grep)
- All 6 remaining Sculptra tiers: conditional (verified by grep)
